Key facts
- This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2025, 16:37.
J. E. Davis - 03 Mar 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- DGX
- Reported as of
- 03 Mar 2025
- Net transaction value
- +$4,968,790
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 16:37:24 UTC
- Prior SEC filing
- 28 Feb 2025
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for James E. Davis
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 05 Mar 2025.
Change
- Previous filing in this sequence was filed on 28 Feb 2025.
- Current net transaction value: +$4,968,790.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Tax liability
- Transaction value
- $288,756
- Shares
- -1,662
- Change %
- -1.2%
- Price
- $173.74
- Shares after
- 136,553
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Award
- Transaction value
- $10,757,460
- Shares
- +61,917
- Change %
- +45%
- Price
- $173.74
- Shares after
- 198,470
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
DGX
transaction
Common Stock
Tax liability
- Transaction value
- $5,499,913
- Shares
- -31,656
- Change %
- -16%
- Price
- $173.74
- Shares after
- 166,814
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
Footnote F2
Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock awards approved in accordance with the requirements of Rule 16b-3(d).
Footnote F3
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock awards.